Purple Biotech Ltd
PPBT
$0.39
Closing
▲7.50%
1D
▼-50.38%
YTD
PPBT
BBG00B3L3T26
Market cap
$11.60M
52 week high
$1.77
52 week low
$0.31
Volume
43,169
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$11.60M
Analysts' Rating
BUY
Price Target (Mean)
7.33
Total Analysts
2
P/E
Operating Margin
0.00%
Beta
1.12
Revenue Growth
0.00%
52 week high
$1.77
52 week low
$0.31
Div. Yield
%
EPS Growth
-26.32
Company Profile
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
